202,00 €
- Aug.
- Okt.
- Nov.
- Jan.
- März
- Mai
- Juni
- Aug.
- 145
- 160
- 180
- 195
- 210
ERTRÄGE
Warnung: Die Dividende wurde um 74,6% gekürzt auf 0,68 € pro Aktie. Dies könnte eine strategische Entscheidung sein oder auf veränderte finanzielle Prioritäten hinweisen. Aktionäre sollten prüfen, ob dies ein isolierter Rückschlag oder ein Zeichen struktureller Probleme ist.
0,68 €
Jährliche Dividende
0,34 %
Rendite
-74,60 %
Dividenden-Wachstum
31,34 %
Ausschüttungsquote
UNTERNEHMEN
10,8 Mrd. $
Umsatz
9,91 %
Umsatz-Wachstum
968,0 Mio. $
Nettogewinn
-
13,5 %
ROE -
8,9 %
ROS -
6,0 %
ROA -
18,4 %
GPM
1,9 Mrd. $
Operativer Cashflow
7,1 Mrd. $
Eigenkapital
55.000
Mitarbeiter
-
197.272,7 $
Umsatz / MA -
17.600,0 $
Gewinn / MA
KGV
21,63 $KBV
2,96 $KCV
15,23 $KUV
1,96 $EV/EBITDA
14,91 $EV/EBIT
19,57 $EV/FCF
21,33 $EV/Umsatz
2,74 $EnterpriseValue
29,7 Mrd. $Eigenkapitalrendite
13,54 %Umsatzrendite
8,92 %EBIT-Marge
13,99 %EBITDA-Marge
18,37 %Kapitalumschlag
0,68 $Gesamtkapitalrendite
6,04 %Eigenkapitalquote
0,45 $Fremdkapitalquote
0,55 $Verschuldungsgrad
1,24 $Dyn. Verschuldungsgrad
4,70 $Sachinvestitionsquote
-0,26 $Anlagendeckungsgrad 1
1,93 $Anlagendeckungsgrad 2
0,98 $Liquidität 1. Grades
0,19 $Liquidität 2. Grades
0,91 $Liquidität 3. Grades
1,17 $Dividende pro Aktie
2,72 $Dividendenrendite
1,45 %Ausschüttungsquote
31,34 %Buchwert pro Aktie
63,41 $Cashflow pro Aktie
16,68 $Stand: 30.09.2025 TTM
Fakten
-
Sitz
USA
-
Hauptsitz
Secaucus
-
Börsengang
17.12.1996
-
Ausstehende Aktien
113,00 Mio.
-
Mitarbeiter
55,00 Tsd.
-
Währung
USD
-
Sektor
Gesundheitswesen
-
Industrie
Medical - Diagnostics & Research
-
Börse
NYSE
-
Ticker
DGX
-
Webseite
Aktie
Unternehmensinfos
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.